POET Technologies Financing Funds Manufacturing Push

POET Technologies Inc. (POET) announced a $400 million registered direct offering on May 15, 2026, following its Q1 results that showed accelerating revenue alongside a wider net loss. Management said the proceeds will fund manufacturing expansion, targeted acquisitions, and increased research and development (R&D).

Q1 Results and Commercial Progress

For the three months ended March 31, 2026, POET described itself as a designer and developer of Photonic Integrated Circuits (PICs), light sources, and optical modules for AI and data-center markets. The company reported non-recurring engineering (NRE) and product revenue of $503,389, up from $166,760 in Q1 2025 and $341,202 in Q4 2025. It recorded a net loss of $12.3 million, or ($0.08) per share, compared with net income of $6.3 million a year earlier and a net loss of $42.7 million in the prior quarter. Other income included $4.0 million in interest, and operating cash flow was negative $8.8 million.

The net loss reflected non-cash charges and investments, including $4.5 million in R&D, $3.4 million in stock-based compensation, and $1.0 million in depreciation. Revenue mainly derived from NRE and product sales related to POET’s Optical Interposer platform for AI and hyperscale data-center customers.

The quarter featured new commercial traction, notably a collaboration framework with Lumilens that included an initial $50 million purchase order and contemplated over $500 million in cumulative purchases over five years. POET also advanced partnerships with LITEON and Lessengers on AI and data-center optical modules.

Registered Direct Offering Details

POET entered a definitive, non-brokered registered direct offering with a single institutional investor to sell 19,047,620 common shares and warrants exercisable for the same number of shares. The combined price per share and warrant was $21.00, raising gross proceeds of $400 million, a premium to the Nasdaq Capital Market closing price of $20.57 on May 14.

The warrants will be exercisable at $26.15 per share for three years. Full exercise would result in 38,095,240 new shares issued. The offering is made under an automatic shelf registration statement on Form F-3 declared effective by the SEC on January 22, 2026. The transaction is expected to close on or about May 18, 2026, subject to customary conditions.

POET said it will use the net proceeds to expand manufacturing infrastructure, support corporate development including targeted acquisitions, scale R&D, accelerate its light-source business, expand operations, and fund general working capital.

The financing announcement also confirmed a chief operating officer appointment and the planned retirement of the chief financial officer.